Bradley Margus

Bradley A. Margus is the founder.
Founded Perlegen Sciences, Inc. in 2000 as Vice Chairman & Chief Executive Officer.
Founded Envoy Therapeutics, Inc. in 2009 as Chief Executive Officer & Director.
Founded Cerevance, Inc. in 2016 as Chairman.
Current job at A-T Children's Project as Chairman.
Current job at Network For Excellence In Neuroscience Clinical Trials as Chairman-External Oversight Board.
Current job at Neurona Therapeutics, Inc. as Director since 2021.
Current job at Presage Biosciences, Inc. as Director.
Current job at Arvinas Operations, Inc. as Director.
Current job at Childrens Neurobiological Solutions as Director.
Current job at Global Genes as Director.
Current job at hC Bioscience, Inc. as Director since 2022.
Current job at National Institute of Neurological Disorders & Stroke as Member.
Former job at Genome Bridge as Chief Executive Officer from 2013 to 2015.
Former job at Genetic Alliance, Inc. as Director.
Former job at Second Genome, Inc. as Director.
Former job at Cellular Research, Inc. as Director.
Former job at Arvinas, Inc. as Independent Director from 2013 to 2022.
Education at George Washington University with an undergraduate degree.
Education at Harvard Business School with an MBA.